Literature DB >> 11448219

Reversible carnitine palmitoyltransferase inhibitors with broad chemical diversity as potential antidiabetic agents.

F Giannessi1, P Chiodi, M Marzi, P Minetti, P Pessotto, F De Angelis, E Tassoni, R Conti, F Giorgi, M Mabilia, N Dell'Uomo, S Muck, M O Tinti, P Carminati, A Arduini.   

Abstract

A series of carnitine related compounds of general formula XCH(2)CHZRCH(2)Y were evaluated as CPT I inhibitors in intact rat liver (L-CPT I) and heart mitochondria (M-CPT I). Derivative 27 (ZR = -HNSO(2)R, R = C(12), X = trimethylammonium, Y = carboxylate, (R) form) showed the highest activity (IC(50) = 0.7 microM) along with a good selectivity (M-CPT I/L-CPTI IC(50) ratio = 4.86). Diabetic db/db mice treated orally with 27 showed a significant reduction of serum glucose levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11448219     DOI: 10.1021/jm010889+

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

Review 1.  Structural insight into function and regulation of carnitine palmitoyltransferase.

Authors:  Arne C Rufer; Ralf Thoma; Michael Hennig
Journal:  Cell Mol Life Sci       Date:  2009-05-09       Impact factor: 9.261

2.  Synthesis and biological activity of 3-[phenyl(1,3-thiazol-2-yl)-amino]propanoic acids and their derivatives.

Authors:  Vytautas Mickevičius; Aušra Voskienė; Ilona Jonuškienė; Ramūnė Kolosej; Jūratė Šiugždaitė; Petras Rimantas Venskutonis; Rita Kazernavičiūtė; Zita Brazienė; Elena Jakienė
Journal:  Molecules       Date:  2013-12-05       Impact factor: 4.411

3.  Carnitine Palmitoyltransferase 1b Deficiency Protects Mice from Diet-Induced Insulin Resistance.

Authors:  Teayoun Kim; Lan He; Maria S Johnson; Yan Li; Ling Zeng; Yishu Ding; Qinqiang Long; John F Moore; Jon D Sharer; Tim R Nagy; Martin E Young; Philip A Wood; Qinglin Yang
Journal:  J Diabetes Metab       Date:  2014-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.